Key facts
- Dr Agarwals Healthcare (NSE: AGARWALEYE)’s last known valuation is $1.5B (Feb 2025).
- It has raised $136.4M; the latest was IPO ($350.9M) in Feb 2025.
- Notable investors include Fidelity, HSBC Holdings, Axis Max Life Insurance, Tiger Pacific Capital (New York), Aditya Birla Sun Life AMC — 17 tracked in total.
- Status: Publicly Held.
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Dr Agarwals Healthcare (NSE: AGARWALEYE)
- ·The full record, as it builds
Funding rounds
No funding rounds for Dr Agarwals Healthcare (NSE: AGARWALEYE) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dr Agarwals Healthcare (NSE: AGARWALEYE)
Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
- Sector
- Healthcare
- HQ
- Chennai, India
- Founded
- 2010
- Employees
- 3,371
- Website
- dragarwals.co.in/
- Ownership
- Publicly Held
Dr Agarwals Healthcare (NSE: AGARWALEYE) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dr Agarwals Healthcare (NSE: AGARWALEYE) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dr Agarwals Healthcare (NSE: AGARWALEYE) in its N-PORT filings yet. We sweep new filings monthly.